Pfizer, maker of erectile dysfunction drug Viagra and its generic, maintains market dominance, even as Viagra (sildenafil) sales are down.

AstraZeneca's China business soared 25% in 2018 as cancer and respiratory drugs pulled through; Pfizer Japan is recalling valsartan combo drugs made using ...

Fishman Jay A Ltd. MI decreased its position in shares of Pfizer Inc. (NYSE:PFE) by 0.6% during the third quarter, according to its most recent 13F filing with the ...

After a great 2018, what's in store for Pfizer in 2019 and the next two years?

In the wake of an Appellate Division ruling invalidating Pfizer Inc.'s electronic distribution of a mandatory arbitration agreement to its workers, companies using ...

KALAMAZOO, MI -- Toxic chemicals from a Pfizer facility entered the Kalamazoo River after passing through the city of Kalamazoo's wastewater system.

Pfizer reported a fourth-quarter loss as the pharmaceutical company faced pricing challenges in the U.S. and tougher generic competition.

Pharmaceutical giant Pfizer braced investors for little-to-no revenue growth in 2019 after its blockbuster erectile dysfunction drug Viagra and others lost patent ...

Pfizer's (PFE) Japanese subsidiary is recalling more than 763K tablets of its hypertension drug Amvalo due to the presence of a carcinogen. The pills were.

Healthcare has given investors great opportunities for a long while, and pharmaceutical specialists in particular have seen plenty of solid gains over time.

Sexual health clinics in southwestern Ontario that offer low-cost birth control say they've had to increase the price of a number of their products?sometimes by ...

Pfizer has been investing heavily in establishing a competitive pipeline of innovative medicines. In-market and innovative brands have driven performance but ...

Pfizer announced that it had submitted both NDA applications to receive FDA approval for tafamidis to treat patients with transthyretin amyloid cardiomyopathy.

Pfizer (NYSE:PFE) recently posted its Q4 results, which were slightly above the street estimates. The company's overall sales grew 5%, while adjusted earnings ...

In a questionable move, the Indian government has tied up with Pfizer.

Pfizer's (PFE) fourth-quarter earnings and sales beat estimates. Its forecast for 2019 falls short of expectations. Stock dips 2% in pre-market trading.

A Pfizer buyout of Amarin is still just a rumor. But rumors sometimes turn into reality.

Union Bankshares Corp decreased its stake in Pfizer Inc (PFE) by 7.77% based on its latest 2018Q3 regulatory filing with the SEC. Union Bankshares Corp sold ...

Pfizer's (PFE) fourth-quarter earnings and sales beat estimates. 2019 forecast falls short of expectations. Stock dips 2% in pre-market.

Pfizer (NYSE:PFE) gave good news and bad news when it reported third-quarter results in October. The big drugmaker beat Wall Street's earnings estimates, but ...

Pfizer Inc. (NYSE:PFE) tinted gains of +0.65% (+0.27 points) to US$41.97. The volume of 18.84 Million shares climbed down over an trading activity of 26.46 ...

Santa Barbara Asset Management Llc decreased Pfizer Inc (PFE) stake by 0.97% reported in 2018Q3 SEC filing. Santa Barbara Asset Management Llc sold ...

Since the start of this financial year stock price of the Pfizer Inc. (NYSE: PFE)has maneuvered across quite a bit, with a year-to-date change of -1.68. By taking a ...

The industry faces headwinds that may become only more acute as scrutiny over drug prices intensifies.

Operational cash flows continue to increase. They continue to cover financing and investing activities. Remaining long. This idea was discussed in more depth ...

While Pfizer's (PFE) new drugs like Ibrance and Xeljanz are likely to drive Q4 sales, genericization of key drugs and weak sales in the EH segment will hurt the ...

Pfizer stock rose after the company's latest earnings report. Although Pfizer's full-year guidance is lower than the Street consensus, analysts are still excited ...

Wms Partners Llc increased its stake in Pfizer Inc (PFE) by 125.28% based on its latest 2018Q3 regulatory filing with the SEC. Wms Partners Llc bought 31321 ...

Pfizer Ireland will begin to transfer 900 employees into a new defined contribution plan from its defined benefit plans on April 1.

Shares of Pfizer and Merck fell on Wednesday after Wall Street downgraded the drugmakers on increased competition and the loss of patent protection.

After five years of negotiations, Pfizer has decided it's time to move employees at plants in Ireland to the same pension plans that the rest of the company's ...

One of the trending stocks on Thursday was Pfizer Inc. (NYSE:PFE). The number of shares transacted for the day under observation was 18843681 contracts.

Pfizer earnings beat forecasts, but the firm gave weak guidance. Pfizer stock fell. Allergan earnings beat, but guidance was mixed. Allergan stock fell.

Which of these dividend-paying pharmaceutical stocks is the best pick right now?

Pfizer Inc. shares PFE, +1.27% slid 2% in premarket trade Tuesday, after the company posted a loss for the fourth quarter and offered guidance that was below ...

Merck and Pfizer have been laggards so far in 2019. Technical warnings occurred on Dec. 4 when both set multiyear highs and both received downgrades.

Pfizer (PFE), Allergan (AGN), AbbVie (ABBV) and Novartis (NVS) report Q4 results.

British drugmaker GlaxoSmithKline in December 2018 laid out plans to combine its consumer-health business with Pfizer's and then spin out the new company.

Pfizer Inc. (PFE) stock managed performance 0.65% over the last week and switched with performance of -1.78% throughout past one month period. The stock ...

Pfizer Inc. (PFE) currently has a Value Composite score of 31. The Value Composite One (VC1) is a method that investors use to determine a company's.

Pfizer (NYSE: PFE) reported Q4 EPS of $0.64, $0.01 better than the analyst estimate of $0.63. Revenue for the quarter came in at $13.98 billion versus the ...

Among the clutch of decisions at the last CHMP meeting was a recommendation for approval of Pfizer's Vizimpro, an EGFR-targeting drug that could challenge ...

In a move that will cost nearly 700 jobs, Bayer will wind down operations at its Robinson, Pennsylvania, site over the next two years. The 569 full-time employees ...

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced that ...

Pfizer (PFE) Q4 results: Revenues: $13,976M (+2.0%); Innovative Health: $8,852M (+7.7%); Essential Health: $5,124M (-6.6%). Internal Medicine: $2,657M ...

Workplace Relations Commission invites both sides to talks to avert strike action that had been due to start on Friday.

Pfizer's (PFE) tafamidis application gets FDA's priority review. Regulatory updates for Roche's (RHHBY) and Bristol-Myers'(BMY) cancer combination drugs in ...

When investors are recalibrating their portfolios they should take a look at current volatility levels and the target weight calculation of a given stock. Pfizer Inc.

Barry Investment Advisors Llc decreased its stake in Pfizer Inc (PFE) by 24.23% based on its latest 2018Q3 regulatory filing with the SEC. Barry Investment Cove ...

Checking in on some recent market action, we have noted that shares of Pfizer Inc. (NYSE:PFE) have been seen trading around the $41.97 mark. Investors ...

The Epoprostenol report divides the market of potential buyers into different groups, or segments/sub segments, based on various characteristics. This press ...

Amy Skuse maintained she was fired because she refused to receive a yellow fever vaccine, which went against her religious beliefs as a Buddhist.

Kempner Capital Management Inc decreased its stake in Pfizer Inc. (PFE) by 53.57% based on its latest 2018Q3 regulatory filing with the SEC. Kempner Capital ...

Pfizer Inc. (PFE) Daily Performance: Pfizer Inc. (PFE) stock negotiated recent volume of 18847248 shares in recent trading session on Thursday Dated ...

Taylor Frigon Capital Management Llc increased its stake in Radcom Ltd. (RDCM) by 114.04% based on its latest 2018Q3 regulatory filing with the SEC. Taylor ...

(MENAFN - GetNews) MRFR is the Leading Brand in The Research Company who Recently Published Erectile Dysfunction Drugs Market Research Reports ...

Investors are preparing for the release of key clinical-development data at the American Society of Clinical Oncology's three-day Genitourinary Cancers ...

Top Health Care Stocks: JNJ: Flat PFE: +0.02% ABT: Flat MRK: +0.20% AMGN: Flat Health care stocks were flat to higher pre-bell Friday. Early movers.

Volume for FireEye, Inc. (NASDAQ:FEYE) decreased on 02/12/19 and the net result is a 0.11 gain from the open. The stock closed with a volume of 8420271 ...

After a disastrous day for gene therapy yesterday, Uniqure is flying the flag for the sector with its haemophilia B gene therapy candidate AMT-061. The group's ...

Chris Kenyon, head of XVA quant modelling at MUFG Securities for Europe, the Middle East and Africa, and Mourad Berrahoui, head of counterparty credit risk ...

Global Hemostats Market Segmentation, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen ...

Mai Wealth Advisors decreased its stake in Pfizer Inc (PFE) by 9.53% based on its latest 2018Q3 regulatory filing with the SEC. Mai Wealth Advisors sold 10094 ...

Cypress Capital Management Llc increased its stake in Bb&T Corporation (BBT) by 9.82% based on its latest 2018Q3 regulatory filing with the SEC. Cypress ...

The ERP5 Rank is an investment tool that analysts use to discover undervalued companies. The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC.

Pfizer has chosen to drop five biosimilar candidates and 150 jobs to divert the funds into developing its late-stage pipeline. The decision was made after an ...

The cinder blocks, insulation and metal that once held up part of the Pfizer plant in Rouses point are now rubble. Demolition of the property is underway less ...

Glynn Capital Management Llc decreased its stake in Veeva Systems Inc. (VEEV) by 19.88% based on its latest 2018Q3 regulatory filing with the SEC. Glynn ...

North America Injectable Drug Delivery Market Segmentation, Type (Injectable Drug Delivery Devices, Injectable Drug Delivery Formulation), Application ...

Consumer complaints about EpiPens were increasing, but its manufacturer wasn't properly looking into those complaints, FDA inspectors warned in 2014.

Stifel Financial Corp increased its stake in Bank Amer Corp (BAC) by 1.48% based on its latest 2018Q3 regulatory filing with the SEC. Stifel Financial Corp ...

Reportsbuzz added a new latest industry research report that focuses on Inflammatory Bowel Disease Treatment market and provides in-depth Global ...

This is a contrast between Novartis AG (NYSE:NVS) and Pfizer Inc. (NYSE:PFE) based on their risk, analyst recommendations, profitability, dividends,

Reportsbuzz added a new latest industry research report that focuses on Collagenase 3 market and provides in-depth Global Collagenase 3 market analysis ...

Veritas Asset Management Llp increased its stake in Pfizer Inc (PFE) by 3.77% based on its latest 2018Q3 regulatory filing with the SEC. Veritas Asset Yhb ...

Southwestern Energy Company (NYSE: SWN) experienced a high price of $4.13 with a low value of $4 at the end of the last trading session, which followed after ...

New England Professional Planning Group Inc decreased its stake in Pfizer Inc (PFE) by 3.43% based on its latest 2018Q3 regulatory filing with the SEC.

The report on the global ?Oncology Biosimilars market? offers detailed data on the Oncology Biosimilars market. Elements such as dominating companies, ...

New England Professional Planning Group Inc decreased its stake in Pfizer Inc (PFE) by 3.43% based on its latest 2018Q3 regulatory filing with the SEC.

In the latest example of a Big Biopharma reducing its biosimilar presence, Pfizer has abandoned five of its preclinical programs. The decision is part of an R&D ...

Adell Harriman & Carpenter Inc increased its stake in Pfizer Inc (PFE) by 1.64% based on its latest 2018Q3 regulatory filing with the SEC. Adell Harriman ...

Alpine Partners Vi Llc decreased its stake in Nxstage Medical Inc (NXTM) by 12.74% based on its latest 2018Q3 regulatory filing with the SEC. Alpine Partners ...

M&T Bank Corp increased its stake in Pfizer Inc (PFE) by 7975612.24% based on its latest 2018Q3 regulatory filing with the SEC. M&T Bank Corp bought 3.91M ...

Daiwa Sb Investments Ltd decreased its stake in Pfizer Inc (PFE) by 89.42% based on its latest 2018Q3 regulatory filing with the SEC. Daiwa Sb Investments Ltd ...

NEW YORK--(BUSINESS WIRE)--Feb 1, 2019--Pfizer today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European ...

The Superior Court of New Jersey, Appellate Division on Wednesday ruled that Pfizer's method of obtaining employee agreement to arbitration was inadequate.

According to the analysis offered by Market Research Future (MRFR), the global chemotherapy market has been presumed to strike a CAGR of 6.2% during the ...

Pfizer's 6% dividend increase is good news. But here's what makes it even better.

Days after the FDA blessed Merck's effort to challenge Pfizer's mega-blockbuster Prevnar 13 with a breakthrough designation, Affinivax is making the leap into ...

Critics often target physicians who receive money from pharma, but the exact influence those payments have on prescribing is up for debate. In oncology, at ...

Global Gabapentin Market 2019-2026 report is a professional and in-depth study on the market overview, market dynamics, competitive analysis, and leading ...

DUBLIN, Feb. 14, 2019 /PRNewswire/ -- The "The Global Pain Therapeutics Market, 6th Edition: Market Trends & R&D Insights" report has been added to...

Neurocrine BiosciencesThe scope of the Report:Get a detailed segmentation of the global Endometriosis market according to the type of product and application ...

Garrison Financial Corp purchased a new stake in Pfizer Inc. (NYSE:PFE) during the third quarter, according to its most recent filing with the Securities ...

This new report by Eon Market Research, titled ?Global Antivenom Market 2019 Research Report, 2015 ? 2025? offers a comprehensive analysis of Antivenom ...

Watching some technical levels for Pfizer Inc (PFE), we have noticed that the current 20-Day Bollinger Bands signal is reading Hold. This indicator may be used.

The stock of Boston Scientific Corporation (NYSE:BSX) witnessed a 54.95% increase from the 52-week low price of $25.84 it recorded on 2018-02-13.

This report focuses on Breast Cancer Treatment Drugs Market 2019-2025 volume and value at global level, regional level and company level. From a global ...

Pfizer Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate. Pdf Link: Pfizer Ltd. - Loss of Share Certificate / Issue of ...

Grisanti Capital Management LLC trimmed its stake in Pfizer Inc. (NYSE:PFE) by 95.2% during the third quarter, according to its most recent disclosure with the ...